Tumor markers TMEM170B albumen and its application in suppression tumour product is prepared

Tumor markers TMEM170B albumen and its application in suppression tumour product is prepared

  • CN 107,064,511 A
  • Filed: 06/09/2017
  • Published: 08/18/2017
  • Est. Priority Date: 06/09/2017
  • Status: Active Application
First Claim
Patent Images

1. a kind of biomarker of tumour, it is characterised in that:

  • Described biomarker is transmembrane protein TMEM170B, its ammoniaBase acid sequence is the SEQ ID NO.1 in sequence table.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×